106 related articles for article (PubMed ID: 23788013)
41. Impact of the Australian National Cervical Screening Program in women of different ages.
Smith M; Canfell K
Med J Aust; 2016 Oct; 205(8):359-364. PubMed ID: 27736623
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
43. [Cervical cancer screening: past--present--future].
Breitenecker G
Pathologe; 2009 Dec; 30 Suppl 2():128-35. PubMed ID: 19756616
[TBL] [Abstract][Full Text] [Related]
44. Differences in Breast and Cervical Cancer Screening Rates in Jordan among Women from Different Socioeconomic Strata: Analysis of the 2012 Population-Based Household Survey.
Al Rifai R; Nakamura K
Asian Pac J Cancer Prev; 2015; 16(15):6697-704. PubMed ID: 26434897
[TBL] [Abstract][Full Text] [Related]
45. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
Sumarmi S; Hsu YY; Cheng YM; Lee SH
Reprod Health; 2021 Jun; 18(1):138. PubMed ID: 34193195
[TBL] [Abstract][Full Text] [Related]
46. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
[No Abstract] [Full Text] [Related]
47. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology.
Sharp L; Cotton S; Thornton A; Gray N; Cruickshank M; Whynes D; Duncan I; Hammond R; Smart L; Little J
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):318-25. PubMed ID: 22921577
[TBL] [Abstract][Full Text] [Related]
48. The potential harms of primary human papillomavirus screening in over-screened women: a microsimulation study.
Naber SK; de Kok IM; Matthijsse SM; van Ballegooijen M
Cancer Causes Control; 2016 Apr; 27(4):569-81. PubMed ID: 26970740
[TBL] [Abstract][Full Text] [Related]
49. Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study.
Jun JK; Choi KS; Jung KW; Lee HY; Gapstur SM; Park EC; Yoo KY
Int J Cancer; 2009 Jan; 124(1):188-93. PubMed ID: 18785204
[TBL] [Abstract][Full Text] [Related]
50. Breast and cervical cancer screening and associated factors among older adult women in South Africa.
Peltzer K; Phaswana-Mafuya N
Asian Pac J Cancer Prev; 2014; 15(6):2473-6. PubMed ID: 24761849
[TBL] [Abstract][Full Text] [Related]
51. Cervical cancer screening coverage in a high-incidence region.
Navarro C; Fonseca AJ; Sibajev A; Souza CI; Araújo DS; Teles DA; Carvalho SG; Cavalcante KW; Rabelo WL
Rev Saude Publica; 2015; 49():17. PubMed ID: 25741655
[TBL] [Abstract][Full Text] [Related]
52. Comment to: Inequalities in adherence to cervical cancer screening in Portugal.
Mihály-Vajda R; Csákvári T; Pónusz-Kovács D; Varga V; Kajos FL; Boncz I
Eur J Cancer Prev; 2022 May; 31(3):310-312. PubMed ID: 35383609
[No Abstract] [Full Text] [Related]
53. Associated factors and global adherence of cervical cancer screening in 2019: a systematic analysis and modelling study.
Zhang W; Gao K; Fowkes FJI; Adeloye D; Rudan I; Song P; Jin M; Chen K
Global Health; 2022 Dec; 18(1):101. PubMed ID: 36494856
[TBL] [Abstract][Full Text] [Related]
54. Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects.
Costa AR; Silva S; Moura-Ferreira P; Villaverde-Cabral M; Santos O; Carmo ID; Barros H; Lunet N
Health Expect; 2017 Apr; 20(2):211-220. PubMed ID: 26914376
[TBL] [Abstract][Full Text] [Related]
55. [Participation indicators of organized cervical cancer screening in Hungary].
Vajda R; Bódis J; Pónusz-Kovács D; Elmer D; Kajos FL; Csákvári T; Kívés Z; Boncz I
Magy Onkol; 2022 Oct; 66(3):186-193. PubMed ID: 36200498
[TBL] [Abstract][Full Text] [Related]
56. Morbidity from cervical cancer: effects of cervical cytology and socioeconomic status.
Lundin FE; Christopherson WM; Mendez WM; Parker JE
J Natl Cancer Inst; 1965 Dec; 35(6):1015-25. PubMed ID: 5856678
[No Abstract] [Full Text] [Related]
57. Trends and Determinants in Uptake of Cervical Cancer Screening in Spain: An Analysis of National Surveys from 2017 and 2020.
Portero de la Cruz S; Cebrino J
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626086
[TBL] [Abstract][Full Text] [Related]
58. The relationship between public risk preference and the underuse or overuse of preventive health services in the information age.
Lu J; Dong Y; Zhang X; Wang Y; Zhou Z
Prev Med Rep; 2024 May; 41():102727. PubMed ID: 38633208
[TBL] [Abstract][Full Text] [Related]
59. Effect of telephone-based health education intervention models on cervical cancer screening compliance: A protocol for systematic review and meta-analysis.
Liu Y; Zhang Q; Chen Y; Wang C
Medicine (Baltimore); 2020 Dec; 99(49):e22130. PubMed ID: 33285666
[TBL] [Abstract][Full Text] [Related]
60. Incidence and mortality due to cervical cancer in 4 south European countries.
Teixeira C; Afonso A; Rodrigues L; Madureira M; Nogueira A
Porto Biomed J; 2019; 4(1):e26. PubMed ID: 31595253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
